<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have developed a reduced-intensity conditioning regimen for patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) undergoing alternative donor transplants, which includes fludarabine (120 mg/m(2)), <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (1,200 mg/m(2)) and antithymocyte globulin (7.5 mg/kg) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">Graft-versus-host disease</z:e> (GvHD) prophylaxis consisted of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>We have enrolled 38 SAA patients in this trial: median age of 14 (3-37) years, transplanted from unrelated (n=33) or family mismatched (n=5) donors, with unmanipulated marrow (n=36) or peripheral blood (n=2) </plain></SENT>
<SENT sid="3" pm="."><plain>Seven patients (18%) had evidence of graft failure, 11% developed grade II-III <z:hpo ids='HP_0011009'>acute</z:hpo> GvHD and 27% developed <z:hpo ids='HP_0011010'>chronic</z:hpo> GvHD </plain></SENT>
<SENT sid="4" pm="."><plain>The actuarial 2-year survival is 73%, with a median follow-up of 621 days </plain></SENT>
<SENT sid="5" pm="."><plain>Younger patients (&lt;or=14 years) had a lower risk of rejection (5%) and improved actuarial survival (84%) </plain></SENT>
<SENT sid="6" pm="."><plain>Causes of <z:hpo ids='HP_0011420'>death</z:hpo> were <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> (n=3), graft failure (n=2), Epstein-Barr virus <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n=2) and <z:mp ids='MP_0001914'>hemorrhage</z:mp> (n=2) </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, the actuarial 2-year survival is encouraging in young SAA patients receiving a radiation-free conditioning regimen </plain></SENT>
<SENT sid="8" pm="."><plain>The significant risk of graft failure in patients 15 years or older may require modification of the conditioning regimen in adults </plain></SENT>
</text></document>